CurePSP has always believed that truly effective clinical interventions will follow good, solid basic scientific research. For this reason, CurePSP promotes research that helps generate an integrated picture of PSP and CBD at pre-clinical and clinical levels. CurePSP believes that in the long term, research of this nature will prove indispensable in developing a prevention or cure for PSP, CBD, and other prime of life diseases.
CurePSP will fund studies on PSP and CBD with a particular interest in (i) molecular and cellular (pathological) mechanisms that may operate also in related diseases and (ii) translational clinical research involving PSP and CBD patients.
CurePSP has carefully structured its research program and has identified the programs that have been the most successful and those that need strengthening. With an increased research budget made possible through improved donor support, CurePSP will be able to markedly intensify the efforts to cure the disease in a way that promises relief for those afflicted today as well as hope for those who may be afflicted tomorrow.
Deadline: March 17, 2023; Oct. 31, 2023CurePSP accepts proposals for research projects from academic and non-academic institutions. CurePSP does not accept applications from any country which is subject to trade sanctions or embargos by the U.S. government or who is a “blocked person” within the meaning of U.S Department of Treasury regulations. All PIs must have an academic degree in science, social work, engineering, or medicine such as a ScD, PhD, MD, MD/PhD, DO, DSW, and DVM degree.
The maximum total grant amount awarded is $100,000. The period of the grant may be up to 3 years in duration but the total cannot exceed $100,000. However, greater or lesser amounts and duration may be offered depending on resources available.